Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis

British Journal of Cancer

Volumn 97, Issue 10, 2007, Pages 1441-1448

  Cheng, Y ^a   Wu, J ^b   Hertervig, E ^a   Lindgren, S ^a   Duan, D ^b   Nilsson, A ^a   Duan, R D ^a  

^a LUND UNIVERSITY   (Sweden)

^b BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

Author keywords

Alkaline sphingomyelinase; ENPP7; HepG2; Human; Liver diseases; Liver tumour

Indexed keywords

ALKALINE SPHINGOMYELINASE; COMPLEMENTARY DNA; GENE PRODUCT; MESSENGER RNA; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL POLARITY; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME ACTIVITY; EXON; GENBANK; GENE EXPRESSION; GENE IDENTIFICATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CARCINOMA; LIVER CELL CARCINOMA; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; SEQUENCE ANALYSIS; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; ENZYME ACTIVATION; EXONS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSCRIPTION, GENETIC;

EID: 36148953306     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604013     Document Type: Article

References (43)

1. Amigo L, Mendoza H, Zanlungo S, Miquel JF, Rigotti A, Gonzalez S, Nervi F (1999) Enrichment of canalicular membrane with cholesterol and sphingomyelin prevents bile salt-induced hepatic damage. J Lipid Res 40: 533-542
2. Broome U, Bergquist A (2006) Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis 26: 31-41
3. Cheng Y, Tauschel HT, Nilsson Å, Duan RD (1999) Administration of ursodeoxycholic acid increases the activities of alkaline sphingomyelinase and caspase-3 in rat colon. Scand J Gastroenterol 34: 915-920
4. Denizot Y, Descottes B, Truffinet V, Valleix D, Labrousse F, Mathonnet M (2005) Platelet-activating factor and liver metastasis of colorectal cancer. Int J Cancer 113: 503-505
5. Di Marzio L, Di Leo A, Cinque B, Fanini D, Agnifili A, Berloco P, Linsalata M, Lorusso D, Barone M, De Simone C, Cifone MG (2005) Detection of alkaline sphingomyelinase activity in human stool: proposed role as a new diagnostic and prognostic marker of colorectal cancer. Cancer Epidemiol Biomarkers Prev 14: 856-862
6. Duan RD (2006) Alkaline sphingomyelinase: an old enzyme with novel implications. Biochim Biophys Acta 1761: 281-291
7. Duan RD, Bergman T, Xu N, Wu J, Cheng Y, Duan J, Nelander S, Palmberg C, Nilsson A (2003) Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family. J Biol Chem 278: 38528-38536
8. Duan RD, Cheng Y, Tauschel HD, Nilsson A (1998) Effects of ursodeoxycholate and other bile salts on levels of rat intestinal alkaline sphingomyelinase: a potential implication in tumorigenesis. Dig Dis Sci 43: 26-32
9. Duan RD, Hertervig E, Nyberg L, Hauge T, Sternby B, Lillienau J, Farooqi A, Nilsson A (1996) Distribution of alkaline sphingomyelinase activity in human beings and animals. Tissue and species differences. Dig Dis Sci 41: 1801-1806
10. Duan RD, Nilsson Å (1997) Purification of a newly identified alkaline sphingomyelinase in human bile and effects of bile salts and phosphatidylcholine on enzyme activity. Hepatology 26: 823-830
11. Duan RD, Nilsson A (2000) Sphingolipid hydrolyzing enzymes in the gastrointestinal tract. Methods Enzymol 311: 276-286
12. Gelderblom WCA, Snyman SD, Abel S, Lebepe-Mazur S, Smuts CM, van der Westhuizen L, Marasas W, Victor TC, Knasmüller S, Huber W (1996) Hepatotoxicity and carcinogenicity of the fumonisins in rats. In Fumonisins in Food, Lackson L et al (eds), pp 279-296. New York: Plenum Press
13. Hertervig E, Nilsson Å, Björk J, Hultkrantz R, Duan RD (1999) Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: a key factor to the unrestrained cell proliferation. Br J Cancer 81: 232-236
14. Hertervig E, Nilsson A, Cheng Y, Duan RD (2003) Purified intestinal alkaline sphingomyelinase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cells. J Cancer Res Clin Oncol 129: 577-582
15. Hertervig E, Nilsson A, Nyberg L, Duan RD (1997) Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Cancer 79: 448-453
16. Lazaridis KN, Gores GJ (2006) Primary sclerosing cholangitis and cholangiocarcinoma. Semin Liver Dis 26: 42-51
17. Leytus SP, Loeb KR, Hagen FS, Kurachi K, Davie EW (1988) A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochemistry 27: 1067-1074
18. Liu F, Cheng Y, Wu J, Tauschel HD, Duan RD (2006) Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells. Cancer Lett 235: 141-146
19. Liu JJ, Nilsson A, Oredsson S, Badmaev V, Zhao WZ, Duan RD (2002) Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells. Carcinogenesis 23: 2087-2093
20. Merrill Jr AH, Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroeder JJ, Riley RT, Voss KA, Wang E (1997) Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol 142: 208-225
21. Merrill Jr AH, Schmelz EM, Wang E, Schroeder JJ, Dillehay DL, Riley RT (1995) Role of dietary sphingolipids and inhibitors of sphingolipid metabolism in cancer and other diseases. J Nutr 125: 1677S-1682S
22. Moschetta A, Portincasa P, van Erpecum KJ, Debellis L, Vanberge-Henegouwen GP, Palasciano G (2003) Sphingomyelin protects against apoptosis and hyperproliferation induced by deoxycholate: potential implications for colon cancer. Dig Dis Sci 48: 1094-1101
23. Murohisa G, Kobayashi Y, Kawasaki T, Nakamura S, Nakamura H (2002) Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin. Liver 22: 394-403
24. Nilsson Å (1969) The presence of sphingomyelin- and ceramide-cleaving enzymes in the small intestinal tract. Biochim Biophys Acta 176: 339-347
25. Nilsson A, Duan RD (2006) Absorption and lipoprotein transport of sphingomyelin. J Lipid Res 47: 154-171
26. Nyberg L, Duan RD, Axelsson J, Nilsson Å (1996) Identification of an alkaline sphingomyelinase activity in human bile. Biochim Biophys Acta 1300: 42-48
27. Ogretmen B, Hannun YA (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4: 604-616
28. Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M, Miyazoe S, Ichikawa T, Ishikawa H, Nakao K, Eguchi K (2003) Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 97: 3036-3043
29. Pardi DS, Loftus Jr EV, Kremers WK, Keach J, Lindor KD (2003) Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 124: 889-893
30. Pettus BJ, Chalfant CE, Hannun YA (2002) Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 1585: 114-125
31. Silins I, Nordstrand M, Hogberg J, Stenius U (2003) Sphingolipids suppress preneoplastic rat hepatocytes in vitro and in vivo. Carcinogenesis 24: 1077-1083
32. Sjöqvist U, Hertervig E, Nilsson A, Duan RD, Ost A, Tribukait B, Lofberg R (2002) Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity. Inflamm Bowel Dis 8: 258-263
33. Spence MW, Burgess JK, Sperker ER (1979) Neutral and acid sphingomyelinases: somatotopographical distribution in human brain and distribution in rat organs. A possible relationship with the dopamine system. Brain Res 168: 543-551
34. Stefan C, Jansen S, Bollen M (2005) NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem Sci 30: 542-550
35. Stoffel W (1975) Chemical synthesis of choline-labeled lecithins and sphingomyelin. Methods Enzymol 36: 533-541
36. Wu J, Cheng Y, Nilsson A, Duan RD (2004a) Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells. Carcinogenesis 25: 1327-1333
37. Wu J, Cheng Y, Palmberg C, Bergman T, Nilsson A, Duan RD (2005a) Cloning of alkaline sphingomyelinase from rat intestinal mucosa and adjusting of the hypothetical protein XP_221184 in GenBank. Biochim Biophys Acta 1687: 94-102
38. Wu J, Hansen GH, Nilsson A, Duan RD (2005b) Functional studies of human intestinal alkaline sphingomyelinase by deglycosylation and mutagenesis. Biochem J 386: 153-160
39. Wu J, Liu F, Nilsson A, Duan RD (2004b) Pancreatic trypsin cleaves intestinal alkaline sphingomyelinase from mucosa and enhances the sphingomyelinase activity. Am J Physiol Gastrointest Liver Physiol 287: G967-G973
40. Wu J, Nilsson A, Jonsson BA, Stenstad H, Agace W, Cheng Y, Duan RD (2006) Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity. Biochem J 394: 299-308
41. Yang S, Lin HZ, Hwang J, Chacko VP, Diehl AM (2001) Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res 61: 5016-5023
42. Yang Y, Nemoto EM, Harvey SA, Subbotin VM, Gandhi CR (2004) Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis. Gut 53: 877-883
43. Zalatan JG, Fenn TD, Brunger AT, Herschlag D (2006) Structural and functional comparisons of nucleotide pyrophosphatase/phosphodiesterase and alkaline phosphatase: implications for mechanism and evolution. Biochemistry 45: 9788-9803